# About Chai Peptide — An Independent Cognitive Peptide Research Desk

> About Chai Peptide: an independent literature digest on DSIP and Semax, two Cognitive & Nootropic research peptides. How it is compiled, what it covers, and what it is not.

An independent, citation-anchored digest on two peptides studied for calm, focus, and sleep. Not a vendor. Not a clinic. Not medical advice.

## What Chai Peptide is

Chai Peptide is an independent editorial reference desk covering the published research on two peptides studied around **calm, focus, and sleep**: DSIP and Semax, with Semax as the lead. The desk exists to translate a scattered and often overstated body of research into plain language — to tell a reader, honestly and with citations, what each compound was actually studied for, in which species, and how far that evidence really reaches.

The organizing idea is a daily rhythm: DSIP anchors the sleep end, Semax anchors the focus end. Reading them together gives a clearer picture of the range of evidence quality in this space than either alone — DSIP's mechanism remains, by researchers' own description, an unresolved riddle, while Semax has a far more specific and measurable mechanism but a much narrower geographic base of human use. Each compound has its own page; a comparison page lines them up side by side; and a single shared references list aggregates every source used across both.

## How it is compiled

Three principles govern what appears on this site.

*First, every research claim is anchored to a numbered citation.* Each factual statement traces back to a source on the [references page](/references) — peer-reviewed journal articles, PubMed-indexed studies, and review articles, with DOIs and PubMed links where available.

*Second, evidence is described at its actual strength, not its marketed strength.* A rodent finding is reported as a rodent finding. A Phase-1980s human pilot study is reported as exactly that — small, old, and not repeated at scale. Where the literature directly contradicts a popular claim about a compound, as with DSIP's sleep evidence, that disagreement is stated plainly rather than smoothed over.

*Third, community and anecdotal reports are kept clearly separate from clinical findings.* Where this desk describes what people say about DSIP or Semax in forums and community writeups, it labels that content as anecdotal, not clinical evidence, and never turns a community report into a dosing suggestion.

## What it is not

Chai Peptide is not a pharmacy, a clinic, a telehealth platform, or a vendor of any kind. It does not sell, supply, source, or broker DSIP, Semax, or any other compound, and it has no affiliate or referral relationship with any research-chemical vendor. It does not employ clinicians, diagnose conditions, or recommend a dose, schedule, or route of administration for any person.

Semax is a registered prescription medicine only in Russia and Ukraine; DSIP is not approved as a medicine anywhere. Readers seeking clinical guidance should consult a licensed healthcare provider in their own jurisdiction. Editorial correspondence on citation corrections or newly published research can be directed to the [contact page](/contact); this desk cannot respond to requests for medical advice.

---

Chai Peptide steeps peer-reviewed findings into plain language — no prescriptions, no products, just a clearer read of what has actually been studied.